Wells Fargo & Company Pulse Biosciences, Inc. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLSE
# of Institutions
77Shares Held
5.41MCall Options Held
139KPut Options Held
84.2K-
Black Rock Inc. New York, NY1.15MShares$20.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$17.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC786KShares$13.9 Million0.0% of portfolio
-
State Street Corp Boston, MA461KShares$8.16 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA457KShares$8.08 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $656M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...